|
SEPARATION AGREEMENT AND GENERAL
RELEASE
In order to settle as fully as possible known and
unknown claims I might have against Aeolus Pharmaceuticals,
Inc. ("Company") and
all related parties, the Company and I, Richard P. Burgoon,
Jr., agree as follows:
|
a.
|
Special Payments : My
termination of employment will be deemed effective as of the close
of business on November 30, 2006 (the "Termination"). Although the
Company has no policy or procedure for providing severance
benefits, the Company will pay me a severance payment (the
"Severance Payment") in the form of a continuation of my base
salary in effect as of immediately prior to the Termination for the
period commencing on December 1, 2006 and ending at the close of
business on February 28, 2007 (the "Transition Period"). The
Severance Payment will be paid to me by check as a lump sum
immediately following the Effective Time (as defined in Section (f)
below). The Company will withhold taxes and report this Severance
Payment to tax authorities as it determines it is required to do. I
acknowledge that the Severance Payment, the Option Payment (as
defined in Section (b) below) and the Additional Option Payment (as
defined in Section (b) below) (the Severance Payment, the Option
Payment and the Additional Option Payment are referred to herein
collectively as the "Separation Payments") and the Continued
Coverage (as defined in Section (g) below) (collectively with the
Separation Payments, the "Transition Benefits") are not otherwise
owed to me and are being provided only in exchange for the promises
made in this Separation Agreement and General Release (the "General
Release"). I will not be required to report to work at the Company
during the Transition Period, and will not be required to perform
regular work assignments. I agree, however, to provide, within
reason, information and guidance, as necessary, to assist in the
transition of my workload. I acknowledge that should I pursue any
claim as described in Section (e) of this General Release ("Claims
Released"), the Transition Benefits will immediately cease and all
other consideration in this General Release will no longer be in
effect.
|
|
b.
|
Stock Option Grants : The
Company acknowledges that as of the date hereof, I have exercised
an aggregate of 145,831 shares of Company common stock (the
"Shares") issuable pursuant to that certain option to purchase up
to 250,000 shares of Company’s common stock, dated July 12,
2005 (the "Stock Option"). As of the Effective Time, the Shares,
which have been held in escrow by the Company on my behalf, shall
be released to me in full and the Company shall have no further
right, title or interest in such Shares. Immediately following the
Effective Time, the Company will pay me a quarterly bonus for the
Company’s fiscal quarter ended September 30, 2006, in an
aggregate amount of $37,707 (the "Option Payment"). The Option
Payment may be paid together with the Severance Payment. The
Company will withhold taxes and report this Option Payment to tax
authorities as it determines it is required to do. I agree to use
an aggregate of $20,833 of the Option Payment for the purchase of
20,833 shares of the Company’s common stock subject to the
Stock Option as of the date hereof (the "Option
Exercise).
|
I am permitted to exercise the remaining
unexercised portion of the Stock Option, which represents an
aggregate of 83,336 shares of Company common stock, after giving
effect to the Option Exercise (the "Remaining Options"), at any
time on or before July 12, 2015, in accordance with the terms of
the Company’s 2004 Stock Option Plan and my Option Agreement
with the Company, dated July 12, 2005. In the event that, on or
before the 12-month anniversary of the date of this General
Release, the Company receives approval of its Board of Directors
and stockholders to consummate a transaction with a party to be
mutually agreed to by me and the Company and listed on
Schedule A attached hereto (the
"Third Party"), pursuant to which the Company would be acquired by,
or merge with, the Third Party (the "Merger"), the Company
acknowledges that I shall be entitled to exercise up to the full
amount of my Remaining Options until immediately prior to the
closing of the Merger, and the Company agrees to (i) pay the full
amount of the exercise price of any such Remaining Options that I
elect to exercise (in an amount of up to an aggregate of $83,336)
and (ii) reimburse me for the following tax obligations that I may
incur in connection with such exercise of the Remaining Options, in
an aggregate amount of up to $67,498.39: (A) federal taxes at
a rate of up 34%; (B) state and local taxes at a rate of up to
9.3%; and (C) all Medicare taxes (collectively, the "Additional
Option Payment").
|
c.
|
Offer Letter : I
acknowledge that as of the Effective Time, the Company shall have
no further obligations to me under that certain Offer Letter, dated
January 5, 2005, between me and the Company, as amended (the "Offer
Letter").
|
|
d.
|
Claims Not Released : This
General Release does not release any claims that the law does not
permit me to release, including but not limited to claims under the
Family Medical Leave Act, the Fair Labor Standards Act, California
Workers’ Compensation, California Family Rights, and Division
3 Article 2 of the California Labor Code (which includes
indemnification rights).
|
|
e.
|
Claims Released :
Except for the claims identified in paragraph (d), this
General Release releases all known and unknown claims that I
presently have against the Company, its current or former owners,
parents, subsidiaries, affiliates, and investors, and their current
or former employees or agents, and any related parties ("Released
Parties") . For example, I am
releasing all claims I have under the Offer Letter, the Stock
Option (except as set forth in Section (b) above), the WARN Act,
Title VII of the Civil Rights Act of 1964, the Age Discrimination
in Employment Act, Sections 1981 and 1983 of the Civil Rights Act
of 1866, the Americans With Disabilities Act, the Employee
Retirement Income Security Act of 1974, and similar state or local
laws such as the California Fair Employment and Housing
Act.
|
|
f.
|
Consideration Period : I
acknowledge that, before signing this General Release, I was given
at least 21 days in which to consider this General Release.
Further, I acknowledge that I have seven days from the date on
which this General Release is executed to revoke my consent to this
General Release. Provided I do not revoke it beforehand, this
General Release will become effective on the eighth day after I
sign this General Release and deliver it to the Company (the
"Effective Time"). I have been encouraged by the Company to discuss
this General Release with my attorney (at my own expense) before
signing it, and I did so to the extent I deemed
appropriate.
|
|
g.
|
Benefit Programs :
I waive future coverage and
benefits under all Company disability programs, but this General
Release does not affect my eligibility for other Company medical,
dental, life insurance, retirement, and benefit plans.
Whether I sign this General Release or not, I understand that my
rights and continued participation in those plans will be governed
by their existing terms, and that I generally will become
ineligible for them shortly after the Effective Time. Following my
separation of employment as of the Effective Time, I will be
eligible to obtain continued health insurance coverage, to be paid
by the Company through June 30, 2007, pursuant to applicable
provisions of COBRA (the "Continued Coverage"). I understand and
agree that if at any time prior to June 30, 2007, I secure any
full-time employment pursuant to which I am eligible to receive
substantially equivalent health insurance coverage, I will
immediately notify the Company in writing and that such Continued
Coverage shall immediately cease. Payments made under this General
Release will not be included in my compensation for purposes of
calculating the benefits to which I am entitled under any employee
benefit program, notwithstanding anything in it to the
contrary.
|
|
h.
|
Confidential and Proprietary Information and Existing
Obligations : Except as may be required by
law, I agree to always keep confidential all proprietary
information of the Company. I understand that "proprietary
information" means information not fully disclosed in writing to
the public and which is treated as confidential within the Company,
or is of value to competitors. I agree to remain bound by any
Company or Company affiliate agreement or policy relating to
confidential information, invention, nonsolicitation,
noncompetition, or similar matters to which I am now subject. In
particular, I acknowledge that in the course of my employment with
the Company, I have obtained confidential, proprietary and/or trade
secret information of the Company, relating to, among other things,
(i) information regarding the Company’s patents, patent
applications, trade secrets, inventions, proprietary and
confidential informat
|
|